Download PDF
Eur J Pediatr Surg 1999; 9: 39-40
DOI: 10.1055/s-2008-1072313
Original article

© Georg Thieme Verlag KG Stuttgart · New York

Bladder Augmentation Surgery - What About the Malignant Risk?

J.  Shaw , M. A. Lewis
  • The North West Regional Spina Bifida Registry, Manchester Children's Hospitals, Hospital Road, Pendlebury, Manchester M27 4HA, UK
Further Information

Publication History

Publication Date:
25 March 2008 (online)

  PDF Download  Permissions and Reprints

Abstract

Augmentation cystoplasty has become a common surgical treatment for the neuropathic bladder. However, malignancy in bladder augmentations has been well-described and in time is estimated to occur in 1.3% of cases.

We surveyed 36 paediatric surgeons from the UK with a special interest in paediatric urology to ascertain how many bladder augmentations were being performed in children each year and whether the surgeons were warning patients/parents of the malignant risks involved with this surgery.

Over 150 bladder augmentations were being performed in the UK each year. Surgeons surveyed were concerned about the malignant risks and nearly all agreed that a Central Registry of patients with bladder augmentations should be established to keep track of developments.

Key words

Neuropathic bladder - Augmentation cystoplasty - Malignancy - Registry

      >